Patents by Inventor Jacob Torres

Jacob Torres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000735
    Abstract: Compositions and methods for supporting health, especially renal health, comprising ketonic agents that recapitulate beneficial effects of ketosis by exogenously administered agents. The agents include beta-hydroxybutyrate (BHB), analogs thereof, and GPR109A agonists. The agents may further include crystal precipitation inhibitors which synergistically improve treatment of certain renal conditions, such as citrate. The agents may be used in dietary supplements and therapeutic compositions for the treatment of cystic kidney diseases such as polycystic kidney disease, ciliopathies, and other conditions. Certain formulations enable convenient administration of the beneficial combination product in powdered form for mixing with liquid. Such formulations can be salt-balanced, and may be free of sodium and/or silicates, and are well tolerated. The formulations may be provided in a container and measuring implement to enable convenient measurement of dosages.
    Type: Application
    Filed: August 4, 2023
    Publication date: January 4, 2024
    Applicants: The Regents of the University of California, Augusta University Research Institute, Inc.
    Inventors: Thomas Weimbs, Jacob Torres, Muthusamy Thangaraju
  • Publication number: 20210244695
    Abstract: Compositions and methods for supporting health, especially renal health, comprising ketonic agents that recapitulate beneficial effects of ketosis by exogenously administered agents. The agents include BHB, analogs thereof, and GPR109A agonists. The agents may further include crystal precipitation inhibitors which synergistically improve treatment of certain renal conditions. The agents may be used in dietary supplements and therapeutic compositions for the treatment of cystic kidney diseases such as polycystic kidney disease, ciliopathies, and other conditions.
    Type: Application
    Filed: April 26, 2021
    Publication date: August 12, 2021
    Applicants: The Regents of the University of California, Augusta University Research Institute
    Inventors: Thomas Weimbs, Jacob Torres, Muthusamy Thangaraju
  • Publication number: 20210244694
    Abstract: Compositions and methods for supporting health, especially renal health, comprising ketonic agents that recapitulate beneficial effects of ketosis by exogenously administered agents. The agents include BHB, analogs thereof, and GPR109A agonists. The agents may further include crystal precipitation inhibitors which synergistically improve treatment of certain renal conditions. The agents may be used in dietary supplements and therapeutic compositions for the treatment of cystic kidney diseases such as polycystic kidney disease, ciliopathies, and other conditions.
    Type: Application
    Filed: April 26, 2021
    Publication date: August 12, 2021
    Applicant: The Regents of the University of California
    Inventors: Thomas Weimbs, Jacob Torres
  • Patent number: 11013705
    Abstract: Compositions and methods for supporting health, especially renal health, comprising ketonic agents that recapitulate beneficial effects of ketosis by exogenously administered agents. The agents include BHB, analogs thereof, and GPR109A agonists. The agents may further include crystal precipitation inhibitors which synergistically improve treatment of certain renal conditions. The agents may be used in dietary supplements and therapeutic compositions for the treatment of cystic kidney diseases such as polycystic kidney disease, ciliopathies, and other conditions.
    Type: Grant
    Filed: March 14, 2020
    Date of Patent: May 25, 2021
    Assignees: The Regents of the University of California, Augusta University Research Institute
    Inventors: Thomas Weimbs, Jacob Torres, Muthusamy Thangaraju
  • Publication number: 20200289444
    Abstract: Compositions and methods for supporting health, especially renal health, comprising ketonic agents that recapitulate beneficial effects of ketosis by exogenously administered agents. The agents include BHB, analogs thereof, and GPR109A agonists. The agents may further include crystal precipitation inhibitors which synergistically improve treatment of certain renal conditions. The agents may be used in dietary supplements and therapeutic compositions for the treatment of cystic kidney diseases such as polycystic kidney disease, ciliopathies, and other conditions.
    Type: Application
    Filed: March 14, 2020
    Publication date: September 17, 2020
    Applicants: The Regents of the University of California, Augusta University Research Institute
    Inventors: Weimbs Thomas, Jacob Torres, Muthusamy Thangaraju